20| OptimEyes Technologies is a biotechnology spin-out company from McMaster University located in Hamilton, Ontario, Canada. They are developing a transformative drug delivery platform for ocular diseases normally controlled by eye drops. Using a patented technology formulation, initially targeted for glaucoma and dry eye diseases, they are able to change the dosing paradigm from twice daily to once every six months.
However, it seems that they are still in the development phase of their technology.
However, it seems that they are still in the development phase of their technology.
Location: Canada, Ontario, Hamilton
Employees: 11-50